Back

Cardiovascular toxicity of targeted cancer therapies.

26 August 2018 (11:00 - 11:22)
Organised by:
Congress Presentation Part of: Cardio-oncology: emerging concepts, challenges and clinical opportunities Cardio-Oncology ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

3 More presentations in this session

Presentation thumbnail
Vascular thrombosis in cancer patients.
Doctor F. Mookadam (Phoenix, US)
Slides Video
Presentation thumbnail
Imaging techniques for detection of cardiac injury after cancer treatment.
Professor A. Barac (Fairfax, US)
Slides Video
Presentation thumbnail
What we can learn from the ESC cardiac oncology toxicity registry.
Professor M. Galderisi (Naples, IT)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology: emerging concepts, challenges and clinical opportunities

The Event

Event poster

ESC Congress 2018

26 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular toxicity surveillance in metastatic breast cancer patients receiving long-term HER2-targeted therapy: a retrospective multicentre study
21 June 2025
thumbnail
Congress Session
Cardio-oncology: when therapy leads to failure
17 May 2025
thumbnail
Congress Presentation
Incidence of acute cardiovascular hospitalizations and association with hemodynamic biomarkers in cancer patients treated with Immune Checkpoint Inhibitor therapy
21 June 2025
thumbnail
Congress Presentation
Adverse cardiovascular events associated with kinase inhibitors and the prognostic value of imaging – a single-center retrospective cohort study in cancer patients
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources